Short Decsription
Creative Biolabs offers HEK293T-Tg(Human Glucagon Receptor) Division-Arrested Cell which Glucagon receptor stably expressed in HEK293T cells.
Description
HEK293T-Tg(Human Glucagon Receptor) Division-Arrested Cell was engineered to express the receptor human Glucagon (NM_000160). This cell line can be used to study Glucagon receptor function, signaling pathways, and potential therapeutic interventions. Dividing-arrest cells are cells that are normally kept under specific culture conditions or treated with agents that prevent cell division from being held in a non-dividing state. This can be achieved through methods such as serum starvation, chemical inhibitors of cell cycle progression, or genetic modification.
Features
Well-characterized stable cell lines;
for cell-based high-throughput screening;
Low-cost evaluation of stable cell lines or limited quantities of compounds.
Applications
Glucagon receptor function, signaling pathways, and potential therapeutic interventions.
Protein Target
GPCR
Receptor Name
Glucagon
Receptor Family
Glucagon
Species
Human
Parental Cell Line
HEK293T
Transfection
Expression vector containing full-length human GCGR cDNA (GenBank Accession Number NM_000160) with FLAG tag sequence at N-terminus
Gene
NM_000160
Background
The human glucagon receptor GCGR mediates the action of the pancreatic peptide hormone glucagon and is mainly present in liver and kidney and to a lesser extent in intestinal smooth muscle, brain, adipose tissue, the adrenal gland, heart, and in pancreatic cells. Glucagon regulates blood glucose via control of hepatic glycogenolysis and gluconeogenesis and via regulation of insulin release from the β cell. Type 2 diabetes is characterized by inappropriate regulation of hepatic glucose production, which is due to an imbalance in the bihormonal relationship between plasma levels of glucagon and insulin. The glucose-lowering effects of glucagon peptide antagonists and anti-glucagon antibodies have demonstrated the potential of glucagon receptor antagonism as a treatment for type 2 diabetes. Glucagon also elicits various effects in extrahepatic tissues, including adipose tissue, kidney, heart, pancreatic β cells, gastrointestinal tract, thyroid and central nervous system.

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2024 Creative Biolabs. All Rights Reserved.